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Abstract 
We investigated whether Encephalopathy with Status Epilepticus during Sleep (ESES) in 
childhood was associated with progressive intellectual decline. Participants were identified 
from the caseload of a single paediatric neurosciences centre and EEG department. A 
retrospective review of overnight sleep EEG reports (n=2200) over a five-year period 
identified twenty-two children as having the neurophysiological characteristics of ESES. 
All had repeat neuropsychological assessment using the WISC-III (UK) and/or WPPSI-R 
(UK).  There was a statistically significant reduction in Full-Scale IQ and Performance IQ 
across a mean and median time interval of 2 years.  Around 1/3 of the participants showed 
a clinically significant regression in intellectual functioning evidenced by =>12 points 
reduction in IQ. These patients were not distinguishable from the rest of the cohort in terms 
of clinical history, imaging or duration of ESES. The reduction in IQ reflected reduced 
processing speed, working memory and overall cognitive efficiency.  Children with a 
history of ESES require close monitoring in order to support educational planning and in 
providing families with accurate information about prognosis. 
 
Keywords: ESES, CSWS, childhood epilepsy, intellectual decline. 
Abbreviations: WISC-III UK: Wechsler Intelligence Scale for children, version 3, UK 
norms; WPPSI-R: Wechsler Primary and Preschool Scale of Intelligence, revised. 
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Introduction 
Encephalopathy with status epilepticus during sleep or ESES is an age-dependent and self-
limited syndrome whose distinctive features include a characteristic age of onset (with a 
peak around 4-5 years), heterogeneous seizures types (mostly focal motor or unilateral 
seizures during sleep and absences or falls while awake), a typical EEG pattern (with 
continuous and diffuse paroxysms occupying a significant proportion of slow wave sleep) 
and a variable neuropsychological regression consisting of IQ decrease, reduction of 
language (as in acquired aphasia or Landau-Kleffner syndrome), disturbance of behaviour 
and motor impairment (in the form of ataxia, dyspraxia, dystonia or unilateral deficit), 
(Tassinari et al 2000). The favourable seizure outcome is independent of the etiology and 
is observed also in cases with cortical malformations such as multilobar polymicrogyria 
(Guerrini et al 1998). The characteristic EEG patterns during slow wave sleep also 
disappear at approximately the same time, but focal interictal spikes may persist (Morikawa 
et al 1989; Bureau 1995).  
 
The first description of sub-clinical electrical status induced by sleep in children dates back 
to 1971 when Patry, Lyagoubi and Tassinari described in 6 children a peculiar EEG pattern 
occurring almost continuously in sleep characterised by apparently ‘subclinical’ spike and 
wave for a variable length of time. Tassinari introduced the term “Electrical status 
epilepticus during slow sleep” and this was originally defined as status epilepticus 
occurring during at least 85% of slow sleep (Tassinari et al. 1977). More recently the 
proportion of affected slow sleep required to affect cognition and behaviour has been 
recognised to be lower, with some authors suggesting a proportion of =>50% can be 
associated with cognitive sequelae. The most typical paroxysmal discharges on EEG are 
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spike wave at 1.5 to 3.5 Hz polyspikes and polyspikes and wave. Secondary bilateral 
synchrony is the mechanism underlying continuous spikes and waves during slow sleep. 
In this respect the apparently generalized seizures (absences, tonic-clonic seizures) 
occurring in this condition have, in fact, a focal onset (Tassinari 1995). ESES can be present 
in various evolutionary stages of a spectrum of diseases, the prototypes of which are 
Continuous Spike and Wave in slow Sleep (CSWS), Landau Klefner Syndrome (LKS) & 
some patients initially presenting with childhood (benign or rolandic) epilepsy with 
centrotemporal spikes (BECTS) (Galanopolou et al, 2000). Children with ESES generally 
demonstrate a global neuropsychological disturbance whereas those diagnosed with LKS 
typically display an isolated language disorder.  In both syndromes recovery of language 
functions may be associated with disappearance of continuous spike and slow wave during 
slow wave sleep. The neuropsychological disturbances are suspected to be a function of 
the genetic or symptomatic origin of the underlying epileptic condition, the cortical area of 
the primary focal paroxysmal activity, the patient's age and the severity and duration of the 
EEG abnormalities (DeNegri 1997).   
 
ESES is a rare disorder although accurate incidence is difficult to determine. Morikawa et 
al found an incidence of 0.5% among 12,854 children evaluated during a 10-year period 
(Morikawa et al, 1995). The Landau-Kleffner syndrome (LKS) and encephalopathy with 
electrical status epilepticus during sleep (ESES) are rare childhood-onset epileptic 
encephalopathies in which loss of language skills occurs in the context of an epileptiform 
EEG activated in sleep. Although in LKS the loss of function is limited to language, in 
ESES there is a wider spectrum of cognitive impairment. The two syndromes are distinct 
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but have some overlap. Whether ESES as a whole should be defined as an independent 
syndrome or as an electroclinical feature of many epilepsy syndromes is a source of debate 
(see Hirsch et al. in this supplement). The duration of electrical status epilepticus during 
slow sleep has been correlated with the final neuropsychological outcome (Rousselle & 
Revol 1995). It has also been suggested that electrical status epilepticus during slow sleep 
is a model for prolonged cognitive impairment induced interictal paroxysmal activity 
(Tassinari 1995). "Interictal paroxysmal activity" may interfere with different cognitive 
processes, as demonstrated by neurophysiological, neuropsychological, and biochemical 
studies (Binnie 1993; Wasterlain et al 1993). There is now increasing evidence that many 
autistic children with a history of language regression have epileptiform abnormalities, 
suggesting a role of subclinical epileptic discharges in relatively common developmental 
syndromes of infancy (Ballaban-Gil et al 1998; Goldberg et al 1998; De Menezes et al 
1998). 
 
Following resolution of ESES, improvement in language dysfunction, learning disability 
and psychiatric disturbances generally occurs but is variable and individualised. The 
majority of affected children never return to normal levels, particularly in verbal and 
attention abilities (Roulet Perez et al 1993; Morikawa et al 1985).  Margari et al  followed 
up 25 patients (19 male) from 2 to 16 years of age (mean age 6 years±3 SD) to examine 
the presence and course of neuropsychiatric disorder (mean duration of follow-up: 3.9 
years) (Margari, 2012). At diagnosis of CSWS, 54% of patients had behavioral problems, 
37.5% mental retardation, 33% learning disabilities, 17% developmental coordination 
disorder, 12.5% language disorder, and 8% pervasive developmental disorder. During the 
follow-up, neuropsychiatric dysfunctions remained unaltered in 52% of the patients, 
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worsened in 24%, and improved in only 24%. The authors suggest that CSWS may be 
associated with a broad spectrum of neuropsychiatric disorders and may promote their 
worsening over time. Despite the apparent developmental impact of the encephalopathy 
associated with ESES there has been very little published related to neuropsychological 
outcomes, with only two very small cohort studies e.g. Seegmüller et al (2012) n=10 
patients, and Scholtz et al (2005) n=7 patients. 
 
The current study aimed to provide data on a larger series of children with treated ESES 
using standardised neuropsychological tests.  We aimed to provide some preliminary data 
on the impact of ESES on the developing brain in terms of intellectual development in 
middle to late childhood. 
 
Methods 
Participants were identified by reviewing reports of 24h ambulatory EEG over a period of 
5 years (n=2200). The recordings of those who exhibited marked sleep accentuation of 
epileptiform activity were reviewed. Those who fulfilled the diagnostic criteria for ESES 
i.e. >85% were identified.  We also included were children who had abnormal activity 
occupying 60-85% of slow wave sleep if there was a history of change in behavior and /or 
recent loss of skills. Children who were in non-convulsive status with a continuous 
dysrhythmia awake and asleep were excluded.  Clinical records were reviewed to 
determine seizure types, aetiology, behavioural and EEG features.   
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This was a retrospective study with cases managed by several clinicians and no uniform or 
standardized therapeutic paradigm for ESES. Cases were treated with several different anti-
epileptic drugs including clobazam, prednisolone and valproate with variability in dose and 
combination of different treatments. In addition, the sequence and duration of different 
therapies was not controlled therefore the data on medication use on individual cases is not 
presented as no valid conclusions can be drawn from this data. 
 
Participants 
Twenty-two participants met inclusion criteria (13m/ 9f). The median age of the sample at 
initial assessment was 6 years (mean 6.8, sd 2.9 years) with a range of 4-16 years. At 
follow-up, the median age was 7.5 years (mean 9.3, sd 3.4 years) with a range of 6-19 
years. This created a mean latency period between assessments of 2.5 years. The clinical 
histories of all patients are described in Table 1. Thirteen participants were reassessed 
within 3 years and 8 participants within 3-5 years. 5/22 had a significant neonatal history 
and 5/22 had abnormal imaging using MRI/CT. There were heterogenous epilepsy types 
(see Table 1).  
 
Measures 
Participants were assessed using the WISC-III (UK-edition) or the WPPSI-R (UK-edition). 
Where patients were unable to complete all subtests of the WISC/WPPSI pro-rated scores 
were derived using statistical techniques outlined within the manual. As this was a 
retrospective study there was no specified time period between the first and subsequent 
neuropsychological evaluations.  
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Insert table 1 
 
Results  
At the time of their initial assessment, nine participants had a measured IQ within the 
learning disability range, four within the severe range (IQ 40-49) and five within the mild 
to moderate range (IQ 50-69). Four participants had an IQ within the borderline range (IQ 
70-79), five had an IQ within the low-average range (80-89), and a further four had an IQ 
within the average range (90-109). At follow-up assessment, thirteen participants had 
measured IQs within the LD range, three within the severe range, and ten within the mild 
to moderate range. Four participants had an IQ within the borderline range, one within low-
average, and four within the average range. Therefore, 41% of the sample had a measured 
IQ within the learning disability range at first assessment compared to 55% at second 
assessment, an increase of 14% (see Figure 1). 
 
Insert Figure 1 
 
As the data were not normally distributed a repeated-measures non-parametric analysis 
(Wilcoxon) was used to compare group median FSIQ, VIQ and PIQ between assessment 
points (see Figure 2). There were significant differences in Full-Scale IQ with a small effect 
size (p=.042; d=0.3); and performance IQ with a medium effect size (p=.031; d=0.4). There 
was no significant difference in VIQ across time (p=.421).  
 
Insert Figure 2 
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Figure 3 shows the change in IQ for each participant and can be correlated with the clinical 
histories shown in Table 1 (Identifying numbers for participants 1-22 correspond between 
Table and Figure).  
 
Insert Figure 3 
 
To address the important issue of statistical versus clinical significance regarding change 
in IQ scores, we analysed the data using a conservative criteria of =>12 point difference in 
IQ.  When adopting this more conservative criteria to denote clinically significant change, 
seven participants were found to show =>12 IQ point change with a mean FSIQ at initial 
assessment of 86 (sd=15), and at follow-up of 67 (sd=14.7) with a large effect size (d=1.3).  
The largest effect was observed in Performance IQ with a mean reduction of 24 points from 
92 to 68 (p=.018, d=1.5). A less dramatic drop in VIQ was observed with an average of 9 
points change (d=0.4).  If excluding those participants who scored at floor value at both 
time points (n=4), our findings suggest that 7/18 participants (38%) showed a highly 
significant intellectual decline affecting FSIQ and PIQ. These individuals tended to move 
from the average range to the mild learning disability range. Four individuals had IQ values 
=<40 (floor value on WISC-III) at both assessments and therefore were not able to be rated 
in terms of on-going cognitive loss using these instruments.   
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Discussion 
We report the largest neuropsychological outcome study of childhood ESES with main 
findings of a clinically and statistically significant decrease in Full-Scale and Performance 
IQ despite treatment. Around one-third (7/22) of participants in the current study showed 
a highly significant loss (=>12pts) in intellectual performance evident particularly within 
their Performance IQ scores within a relatively short period of time (2.5 years). These 
individuals tended to move from the average range to the mild learning disability range 
and were not distinguishable from the rest of the sample in terms of clinical history, 
imaging or duration of ESES.  Performance IQ (PIQ) effects were more pronounced than 
verbal IQ, a finding of interest as language difficulties are the most commonly reported 
difficulties in these children. The drop in PIQ may reflect reduced processing speed, 
working memory and overall cognitive efficiency. 
 
Whilst there have been several descriptions of the clinical and behavioural manifestations 
of ESES, few have used standardised tests to look at cognitive function. In a report of 
longitudinal neuropsychological outcome in 10 patients followed from the time of 
diagnosis into adulthood (mean follow-up duration of 15.6 years) six patients had an IQ 
<70, two had a low IQ (77 and 84), and two had an IQ within the average range (103 and 
85) (Seegmuller et al. 2012). The authors also describe social, cognitive and attention 
difficulties in the majority of the patients. They suggest that the initial severity and duration 
of the acute phase regression and the duration of ESES were most predictive of poorer 
neuropsychological outcome. In another report it was suggested that the initial diagnosis 
had little prognostic significance, but that length and the age of onset of CSWS, the site of 
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epileptiform activity and the individual neuropsychological profile are more useful for 
predictors long-term cognitive outcome (Veggiotti, 2012). 
 
Our study has limitations as a result of the retrospective nature and lack of control over 
timing of assessments and therapeutic interventions. The value of the report lies in the 
serial neuropsychological evaluations in individuals which demonstrate the clinical impact 
of ESES.  Controlled trials in ESES are required to help determine what might be the most 
effective treatments. Recently the Rescue ESES international European collaboration has 
developed such a trial. Unfortunately, due to the rarity of the condition, the challenges of 
multi-centre trial bureaucracy and variability in resources to support the trial assessments, 
this study has not recruited as well as planned. It is possible that international agreements 
between collaborating centres to collect data and manage patients in a limited number of 
standardized paradigms might be the most practical way to generate sufficient clinically 
useful data on treatment efficacy. 
 
The implications of our study are that whilst some children experience stagnation in 
development, represented by a plateau in neuropsychological test scores and a 
corresponding decline in age-normative standard scores, others experience a more 
significant decline in cognitive function consistent with an active disease process. In this 
group of children with ESES with a variety of underlying aetiologies and treatments, the 
underlying encephalopathy resulted in an insidious decline in cognitive ability. It is 
therefore important that children with ESES have early and continuing neuropsychological 
assessment and that developmental monitoring is linked with appropriate psychological, 
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social and psychiatric support to improve mental wellbeing and social participation. 
Families and educational services should also be provided with accurate information to 
inform prognosis and support in relation to maximizing learning potential and social 
integration with peers. 
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Table 1. Clinical history showing IQ, seizure type, age of onset, imaging and other clinical phenomena for each participant. 
 
Patient IQ 1 IQ 2 Neonatal 
History 
Developmental 
History 
Age of 
Onset 
Type  
Of 
epilepsy 
Age at 
Diagnosis 
of ESES 
Clinical  
Presentation at 
diagnosis 
Maximum 
Epileptic 
Activity 
Imaging 
1 77 65 Uneventful Febrile seizure 
aged 2.5 years 
2.5 years Generalised and focal 
epilepsy of unknown 
aetiology 
3 years No cognitive / 
behavioural 
concern 
Right 
hemisphere 
emphasis 
CT normal 
2 77 68 Uneventful Normal; mild 
dyspraxia 
4 years  Atypical Childhood 
Epilepsy with 
Centrotemporal Spikes 
5 years   
 
Language 
difficulties  
Assymetrical 
ESES, right 
hemisphere 
emphasis 
CT normal 
3 89 56 Hydroceph
alus 
secondary 
to 
aqueduct 
stenosis 
VP shunted 2 
months; 
Right hemi 
paresis; 
Global cognitive 
delay   
4 years Focal epilepsy with 
structural aetiology 
8 years Language and 
social 
communication 
difficulties 
Left 
hemisphere 
CT Left sided 
peri-ventricular 
white matter 
loss; 
PVL 
4 40 69 Uneventful Uneventful 6 years Focal epilepsy with 
unknown aetiology 
6 years Language and 
social 
communication 
difficulties 
Left 
hemisphere 
emphasis 
(temporal). 
MRI normal 
5 105 78 Uneventful Normal >1 year Generalised Epilepsy 
with myoclonic 
seizures (unknown 
aetiology) 
4 years  No cognitive 
regression noted 
Bilateral MRI normal 
6 98 99 Uneventful Delayed motor 
development 
7 months Focal epilepsy with 
unknown aetiology 
5 years Poor educational 
progress 
Bilateral MRI normal 
7 108 108 Premature 
26 weeks 
gestation,  
Acquired brain 
injury aged 7 
years,  
10 years Generalised and Focal 
Epilepsy with structural 
aetiology  
11 years Memory and 
learning problems 
Left 
hemisphere 
emphasis 
(temporal) 
MRI normal 
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8 40 40 Uneventful Global 
developmental 
delay, behaviour 
problems 
5 years Generalised and focal 
epilepsy of unknown 
aetiology 
5 years Severe ongoing 
behavioural 
problems 
bilateral MRI normal 
9 40 40 Uneventful Global 
developmental 
delay 
4 years Focal epilepsy of 
unknown aetiology 
10 years Increasing 
concern over poor 
language and 
learning 
 
 
Left emphasis 
MRI showed 
corpus-callosum 
abnormality 
10 81 75 Uneventful Restricted 
interests, rigid 
behaviour 
3 years Focal epilepsy of 
unknown aetiology 
8 years Continuing 
concerns 
Right sided 
ESES 
MRI abnormal, 
right-sided peri-
ventricular 
leukomalacia 
11 81 75 Uneventful Specific 
learning 
difficulties/clum
sy 
6 years Focal epilepsy of 
unknown aetiology 
6 years  Educational 
difficulties 
Bilateral Awaiting 
12 65 50 Uneventful Global 
developmental 
delay 
5 years Focal epilepsy of 
unknown aetiology 
6 years Continuing 
developmental 
concerns 
Bilateral MRI normal 
13 
 
79 62 Neonatal 
seizures 
Mild right 
hemiplegia;  
1st week of 
life 
Focal Epilepsy with 
structural aetiology 
7 years Reduced 
concentration and 
deterioration in 
memory/ 
reading 
Left sided 
(occipital) 
ESES 
MRI Hemi-
megalencephaly 
14 59 56 Premature 
32/40, 
severe 
IUGR, 
Whooping 
cough aged 2 
years 5 months 
Aged 5.5 
years 
Childhood Epilepsy 
with Centrotemporal 
Spikes 
7 years Language 
difficulties, poor 
educational 
progress 
Bilateral none 
15 69 69 Neonatal 
seizures 
Left hemiplegia, 
learning 
disabilities  
15 years  Focal Epilepsy with 
structural aetiology 
15.5 years Deterioration in 
school work 
Bilateral with 
Right 
hemisphere 
emphasis 
MRI Right 
Schizencephaly 
16 78 69 Uneventful normal 3 years  Myoclonic atonic 
epilepsy 
3 years Behavioural, 
motor and 
cognitive 
regression 
Bilateral MRI normal 
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17 82 88 Uneventful Delayed speech 
and language 
development 
3 years  Focal epilepsy with 
unknown aetiology 
3 years Continuing 
speech delay 
Bilateral with 
shifting 
emphasis 
MRI normal 
18 40 40 Uneventful Mutism aged 4 
years, normal 
speech 
development 
prior 
Aged 4  Landau Kleffner 
Syndrome 
4 years Continuing 
aphasia 
Focal ESES 
left 
hemisphere 
MRI normal 
19 106 92 Uneventful None 5 years Myoclonic  Atonic 
Epilepsy 
5.5 years Concentration, 
school difficulties 
bilateral MRI normal 
20 82 70 Uneventful Normal 
development 
3 years Focal epilepsy with 
unknown aetiology 
8 years Concentration, 
school difficulties 
bilateral Awaiting 
21 65 69 Uneventful Mild learning 
difficulties, late 
childhood 
diagnosis of 
Tourettes 
Syndrome 
treated with 
haloperidol 
11 years  Focal epilepsy with 
unknown aetiology 
12 years  Continuing 
concentration 
problems 
Right sided 
ESES 
Normal MRI 
22 110 105 Uneventful
  
Accidental 
asphyxia aged 
5yrs associated 
with status 
epilepticus. 
2.5 years Focal epilepsy with 
structural aetiology 
6.5 years Memory and 
learning 
Bilateral with 
right sided 
emphasis 
Normal MRI 
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